Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.58%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+27.58%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$22.8B
AUM Growth
-$62.8B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,611
New
Increased
Reduced
Closed

Top Buys

1 +$1.29B
2 +$632M
3 +$61.4M
4
HON icon
Honeywell
HON
+$55M
5
LRCX icon
Lam Research
LRCX
+$52.5M

Top Sells

1 +$2.93B
2 +$2.87B
3 +$1.45B
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.4B
5
AMZN icon
Amazon
AMZN
+$1.34B

Sector Composition

1 Technology 26.05%
2 Financials 11.24%
3 Communication Services 9.29%
4 Healthcare 8.48%
5 Consumer Discretionary 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRAL
1101
GRAIL Inc
GRAL
$2.56B
-89
NEE.PRS
1102
NextEra Energy 7.299% Corporate Units
NEE.PRS
$2.27B
-54,312
UCB
1103
United Community Banks
UCB
$3.84B
-2,208,179
GAP
1104
The Gap Inc
GAP
$7.69B
-42,200
EMEQ
1105
Nomura Focused Emerging Markets Equity ETF
EMEQ
$496M
-428,584
SOBO
1106
South Bow Corp
SOBO
$7.78B
-646
ARES.PRB
1107
Ares Management Corp 6.75% Series B Preferred Stock
ARES.PRB
$1.23B
0
BA.PRA
1108
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$8.14B
-54,274
JBTM
1109
JBT Marel
JBTM
$6.53B
-70,672
SAIL
1110
SailPoint Inc
SAIL
$7.66B
-1,544
SGI
1111
Somnigroup International
SGI
$13.2B
-129,467
CTEV
1112
Claritev Corp
CTEV
$236M
-1,204
JOYY
1113
JOYY Inc
JOYY
$2.84B
-17,282
OTF
1114
Blue Owl Technology Finance Corp
OTF
$5.17B
-29,443
G icon
1115
Genpact
G
$4.92B
-38,200
GBCI icon
1116
Glacier Bancorp
GBCI
$5.93B
-65,124
GH icon
1117
Guardant Health
GH
$12.6B
-328,049
GHM icon
1118
Graham Corp
GHM
$1.09B
-747
GIB icon
1119
CGI
GIB
$13.2B
-1,900
GKOS icon
1120
Glaukos
GKOS
$8.46B
-600,228
GLRE icon
1121
Greenlight Captial
GLRE
$581M
-1,117
GLUE icon
1122
Monte Rosa Therapeutics
GLUE
$1.53B
-200,000
GOLF icon
1123
Acushnet Holdings
GOLF
$5B
-547,119
GOVT icon
1124
iShares US Treasury Bond ETF
GOVT
$40.7B
-633,927
GPCR icon
1125
Structure Therapeutics
GPCR
$2.75B
-58,000